Transo-Pharm Handels-GmbH and HAPILA GmbH are determined to deepen their relationship and have therefore jointly decided to expand the production capacities at the HAPILA site in Gera, mainly to meet the increasing demand for the active ingredient Estriol Micronized.
The planning for the construction and installation work started in 2020.
The new facility is expected to be completed in 2022.
For more information please download attachements (German or English available).
We are going through some difficult times, asking a lot from all of us across the globe. During this holiday season, we wish everyone an enjoyable time with their families and friends – may you all find peace and comfort in the company of your loved ones. The Transo-Pharm crew wishes you a happy and safe New Year.